αCD147 (an anti-CD147 antibody) suppressed the splenic inflammatory response induced by cerebral ischemia, as evidenced by a decrease in splenic cytokine (TNFα, IL-6, IL-1β) and MCP-1 expression at 4h and 24 h after ischemia. This evidence concerns the gene BSG and brain ischemia.